A(Agilent Technologies, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-10-31 | FY 截至 2022-10-31 | FY 截至 2023-10-31 | FY 截至 2024-10-31 | FY 截至 2025-10-31 |
|---|---|---|---|---|---|
| 营业收入 | $6.32B | $6.85B | $6.83B | $6.51B | $6.95B |
| 毛利润 | $3.41B | $3.72B | $3.46B | $3.54B | $3.64B |
| 营业利润 | $1.35B | $1.62B | $1.35B | $1.49B | $1.48B |
| 净利润 | $1.21B | $1.25B | $1.24B | $1.29B | $1.30B |
| 经营现金流 | $1.49B | $1.31B | $1.77B | $1.75B | $1.56B |
| 自由现金流 | $1.30B | $1.02B | $1.47B | $1.37B | $1.15B |
| 摊薄每股收益 | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |